Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma—A randomized phase II trial

Authors:

Abstract
No abstract available
Funding Information
  • Department of Health, Government of Western Australia (NHRI-CN-CA9201S, NHRI-CN-CA9501S)
  • Ministry of Education
  • National Health Research Institutes (95R0066-BM01-02)

This publication has 51 references indexed in Scilit: